Bank of Montreal’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,011
Closed -$125K 3899
2024
Q2
$125K Sell
22,011
-155
-0.7% -$897 ﹤0.01% 3172
2024
Q1
$152K Buy
22,166
+390
+2% +$2.73K ﹤0.01% 3153
2023
Q4
$154K Sell
21,776
-6,420
-23% -$36.3K ﹤0.01% 3237
2023
Q3
$165K Buy
+28,196
New +$168K ﹤0.01% 3133

Other funds holding CLPT

Bank of Montreal's CLPT Position: Q3 2024 in Review

Bank of Montreal sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 22,011 shares — an estimated $125K sold.

Bank of Montreal first reported a position in CLPT in Q3 2023 and held it in 4 quarters. The position peaked at $165K in Q3 2023. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

  • Bank of Montreal reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 22,011 ClearPoint Neuro shares in Q3 2024, an estimated $125K.
  • Bank of Montreal first reported a position in ClearPoint Neuro in Q3 2023 and held it in 4 quarters.
  • Bank of Montreal's ClearPoint Neuro position peaked at $165K in Q3 2023.
  • 78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.